Comparison of 3% Ciprofloxacin-1% Dexamethasone and 10% Ichthammol Glycerin for Control of Pain due to Acute Otitis Externa by Raffat Mustafa, Sadaf
                            260 JIMDC   2017  260 
Open Access 
Ful l  Length  Ar t ic le  
Comparison of 3% Ciprofloxacin-1% Dexamethasone and 10% Ichthammol 
Glycerin for Control of Pain due to Acute Otitis Externa 
 
Sadaf Raffat Mustafa 
Assistant Professor, Department of ENT, Railway Hospital, Rawalpindi 
 
A B S T R A C T  
Objective: To compare the efficacy of 10% Icthammol glycerin and 3% ciprofloxacin-1% Dexamethasone for controlling 
pain associated with acute otitis externa. 
Patients and Methods: This cross-sectional study conducted at the ENT department of Railway Hospital, Rawalpindi 
from 1st March to 1st December 2017. Sixty (n=60) patients of both gender between age 12-60 years, diagnosed with 
moderate to severe acute otitis externa were enrolled and were randomly divided into two groups using lottery method. 
Group A patients were administered 3% ciprofloxacin-1% Dexamethasone wick in auditory canal and Group B patients 
were administered 10% Icthammol Glycerin wick. The treatment was considered efficacious if there was marked 
reduction in pain (pain score decreased to ≤ 4 points from baseline on Visual Analog Score on day 3). 
Results: Baseline characteristics were similar in both groups. Mean VAS was 6.67 ± 1.18SD in group A and 6.57 ± 
1.16SD in group B (P=0.743) at baseline and was 2.43 ± 1.16SD and 3.50 ± 2.16SD, respectively on day 3 (P=0.028). 
Efficacy was significantly better in Group A patients as compared to Group B (76.7%, n=23/30 versus 43.3%, n=13/30; P 
=0.008). 
Conclusion: Treatment with 3% ciprofloxacin-1% Dexamethasone was found to be significantly better than 10% 
Icthammol glycerin in patients with acute otitis externa in terms of associated pain control. 
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I n t r o d u c t i o n  
 
Otitis externa is a common ear condition that affects 
individuals of all ages.1 It occurs in approximately 10% of 
the population, especially in warm and damp climates or 
in swimmers (swimmer's ear). Other predisposing factors 
include, local trauma, maceration, external devices, 
anatomic abnormalities, dermatitides and canal 
obstruction, which might make the canal epithelium 
susceptible to infections.2 Both external auditory canals 
are affected in approximately 10% of cases. Otitis Externa 
can be secondary to dermatitis (eczema) only, with no 
microbial infection or can be caused by active bacterial or 
rarely fungal/viral infection. Pseudomonas aeruginosa and  
Staphylococcus aureus are the two most commonly 
isolated organisms.3 Management depends on severity of 
disease. Mild disease is characterized by minor 
discomfort and pruritus with minimal canal edema and is 
usually treated with an acidifying agent and a 
glucocorticoid (acetic acid with hydrocortisone). Topical 
antibiotic are usually not recommended. Moderate 
disease is characterized by an intermediate degree of 
pain and pruritus with canal may be partially occluded and 
treatement by a topical preparation combination that is 
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acidic and contains an antibiotic, an antiseptic, and a 
glucocorticoid is usually preferred. The antibiotic should 
have coverage against Staphylococcus aureus  and 
Pseudomonas aeruginosa. Cipro HC (ciprofloxacin and 
hydrocortisone) and Cortisporin (neomycin, polymyxin, 
and hydrocortisone) are good first-line agents. Severe 
disease is characterized by intense pain, and canal is 
completely occluded due to edema. Fever, peri-auricular 
erythema, and regional lymphadenopathy may be 
present. For patients with severe disease, management 
includes topical therapy, wick placement, and, if there is 
evidence of deep tissue infection, oral antibiotics are 
recommended.4 Various studies reported the use of 
topicalGlycerol/Ichthammolwick, eomycin/Betamethasone 
wick,5 3% Ciprofloxacin - 1% Dexamethasone6 oral 
ciprofloxacin 500 mg 7 for the treatment of bacterial otitis 
externa in terms of relief of pain.  
There is still no agreement upon the use of prescribed 
drugs in the treatment of acute otitis externa and no drug 
is considered as the drug of choice. Present study is 
designed to evaluate two different kinds of treatments in 
our local population. This will help the ENT surgeons in 
offering the better one in those patients. Patients will be 
benefited in terms of better pain control which is quite 
disturbing and effects the overall quality of life. The 
primary aim of present study was to compare efficacy of 
10% Ichthammol glycerin and 3% ciprofloxacin - 1% 
Dexamethasone in treatment of moderate to severe acute 
otitis externa in terms of Pain reduction. 
P a t i e n t s  a n d  M e t h o d s  
It was a randomized controlled trial cross-sectional 
descriptive study conducted at the ENT department of 
Railway Hospital, Rawalpindi. Study was conducted for a 
period of nine months from 1st March 2017 to 1st 
December 2017. Sample size was calculated by taking 
level of significance as 5%, power of test as 80%, 
anticipated Population proportion 1 as 76%, anticipated 
Population proportion 2 as 38%.6 Patients of both gender 
between ages 12 to 60 years, who were diagnosed with 
moderate to severe acute otitis externa were enrolled in 
the study. Otitis externa was diagnosed on history and 
clinical examination, a characteristic history of 
excruciatingly severe pain, ≥ 5 on visual analogue scale 
in the ear, which was exacerbated by tragal pressure and 
when the auricle was pulled superiorly. On Otoscopy, the 
tympanic membrane was only partially visible due to 
edema of external auditory canal. Ottitis media was 
excluded by otoscopy, no fluid was seen and tympanic 
membrane was normally moving on gentle puffing of air. 
Patients with a history of acute/chronic suppurative otitis 
media, patients suffering from local allergic conditions like 
eczema and psoriasis, patients with bilateral otitis externa 
and patients using hearing aids were excluded from the 
study. Severity of pain was recorded twice, baseline pain 
score on the first day and follow up pain score three days 
after intervention by using Visual analog score 0-10. 
Patients needing aural packing were randomly divided 
into two groups using lottery method. Group-A patients 
were administered 3% ciprofloxacin-1% Dexamethasone 
and Group-B patients were administered 10% Icthammol 
Glycerin. All the enrolled patients were inquired about 
history for pain, discharge, use of hearing aid, diabetes 
and nay sort of allergy. Patients were then examined for 
tragal tenderness and presence of discharge/debris. After 
necessary suction clearance topical 3%Ciprofloxacin-
1%dexamethasone wick was placed in auditory canal of 
group-A patients and Icthammol Glycerine wick  was 
placed in group-B. Same dose of analgesics was given to 
both groups of patients (mefenamic acid 500mg TDS). 
The baseline Pain score was determined using VAS. As 
per the treatment protocol Oral antibiotic (Co-Amoxiclav) 
was also prescribed to patients in both groups, Follow up 
visits was made on 3rd day after starting the treatment. 
On first follow up visit (3rd day) after necessary suction 
clearance new wicks were placed and patients were 
inquired about the severity of pain which was scored 
using VAS.  
The treatment was considered efficacious if there was 
marked reduction in pain (pain score decreased to ≤ 4 
points from baseline on Visual Analog Score (VAS) on 
day 3). All the demographic data recorded on the 
predesigned proforma and statistical analysis of data was 
performed using statistical software SPSS-version 22. 
Descriptive statistics were used to calculate mean and 
standard deviation for quantitative variables like age and 
pain scores at baseline and at day 3 after treatment. 
Frequencies and percentages were presented for 
qualitative variable like gender and efficacy. Efficacy in 
both groups was compared using the chi-square test and 
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P ≤0.05 was considered statistically significant. Mean 
VAS at baseline and at day 3 was also compared in both 
groups by applying student t-test for independent samples 
P-value ≤0.05 considered as significant. 
R e s u l t s  
A total of sixty (n=60, 30 in each group) patients were 
included in the study. Baseline characteristics were 
similar in both groups. Age and gender distribution is 
presented in table 1. Mean baseline VAS was also similar 
in both groups with 6.67 ± 1.18SD in group A and 6.57 ± 
1.16SD in group B (P=0.743). After three days of 
intervention significance difference was noted in VAS with 
group-A showing mean score of 2.43 ± 1.16SD and 
Group-B showing a mean score of 3.50 ± 2.16SD 
(P=0.028). VAS results are tabulated in table 2. Efficacy 
as per our operational definition (pain score decreased to 
≤ 4 points from baseline VAS on day 3) was significantly 
better in patients treated with 3% Ciprofloxacin-1% 
dexamethasone (Group A). A total of 76.7% (n=23/30) 
patients in group A reported treatment was efficacious as 
compared to 43.3% (n=13/30) in group B (P=0.008). 
Efficacy results are tabulated in table 3.  
Table1: Age and Gender distribution in both groups 
 Group 
Gender 3% cipro-1% dexa 
10% icthammol 
Glycerin 
Males 21(70%) 20(66.7%) 
Females 9(30%) 10(33.3%) 
Total 30(100%) 30(100%) 
Mean age  
(years±sd) 
42.5±12.1 41.2±12.1 
 
Table 2: VAS in both groups (baseline and at day 3) 
VAS Group Mean+SD P-Value 
Baseline 
3% cipro1%-dexa 6.67+ 1.184 
0.743 10% icthammol- 
glycerin 
6.57+1.165 
Day-3 
3% cipro1%-dexa 
10% icthammol-
glycerin 
2.43+1.43 
3.50+2.16 
0.028 
Table 3: Efficacy of treatment in both groups 
Efficacy 
Group 
P-value 
3% cipro-1% dexa 
10% icthammol 
Glycerin 
Present 23976.7%) 13(43.3%) 
0.008 Absent 7(23.3%) 17(56.7%) 
Total 30(100.0%) 30(100.0%) 
 
D i s c u s s i o n  
Acute otitis externa (infection of external ear) is most 
often infectious in origin, and can be easily treated with a 
combination of topical antibiotic and steroid preparations.8 
There is no definite agreement upon the use of prescribed 
drugs.9 Cleaning of the meatus by an ENT specialist and 
local application of a broad-spectrum antibiotic or an 
antiseptic is all what required for treating an 
uncomplicated infection.10 Pain associated with acute 
ottitis externa is bothersome for patients. Different 
therapies are being used for pain control.  Present study 
results showed that pain control was significantly better in 
patients treated with 3% ciprofloxacin-1% 
Dexamethasone as compared to patients treated with 
10% Icthammol glycerin (P<0.743). Our results are similar 
with a recent study in local population. Abid et al 
compared the efficacy of topical Glycerol/Ichthammol wick 
(group A) with Neomycin/Betamethasone wick (group B) 
in treatment of bacterial otitis externa in terms of relief of 
pain.  They demonstrated that pain relief was better in 
group A (19.8% no pain, 48.1% mild pain) as compared to 
Group B (15.4% no pain, 24.7% mild pain) patients on the 
third day of treatment (P<0.05).5 In another recent study, 
Jamalullah et al compared the efficacies of 3% 
Ciprofloxacin - 1% Dexamethasone (group A) and 10% 
Icthammol glycerine (Group B) in treatment of otitis 
externa in terms of pain relief. They reported that on third 
day in group A, 76% (n=38) patients had marked, 14% 
(n=7) had moderate and 10% (n= 5) had mild reduction of 
pain. On the other hand, group B patients reported 
marked pain reduction in 38% (n=19) moderate reduction 
in 30% (n= 15) and mild pain in reduction 32% (n=16).6 
Adhikari et al  compared 10% Icthammol glycerin wick 
with steroid antibiotic wick in treatment of otitis externa in 
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children. They reported that use of steroid antibiotic pack 
resulted in earlier relief of pain as well as significantly 
lesser number of visits (P<0.05).10 Masood and 
colleagues studied Triadcortyl with Icthammol glycerin in 
treatment of otitis externa. They demonstrated that both 
treatment modalities were efficacious in the treatment of 
severe acute otitis externa and there was a statistically 
significant improvement of pain parameters in the 
Triadcortyl group.11 The lower efficacy of Icthymol glycerin 
is attributed to its lower antimicrobial activity against gram 
negative organisms. Ahmed et al studied antimicrobial 
activity of Icthammol against otitis externa pathogens 
measured by a growth inhibition test and a modified cidal 
assay. They reported that inhibition of selected gram 
positive organisms (Streptococcus pyogenes and 
Staphylococcus aureus) by Icthammol and Glycerine-
Icthammol combination, but only negligible antibacterial 
activity against Pseudomonas aeruginosa and 
Escherichia coli.12 Candida albicans was also weakly 
inhibited.  Authors suggested that due to minimal activity 
against gram negative organisms, incorporation of an 
anti-gram negative antibiotic such as Gentamicin in the 
Glycerine-ichthammol compound to enhance its 
antibacterial spectrum. Mösges et al compared the 
efficacy of treatment using a Ciprofloxacin 0.2% solution 
with other therapeutic options. The research groups 
consistently observed high in vitro activity of Ciprofloxacin 
against Pseudomonas aeruginosa, confirms the 
hypothesis of superior efficacy of Ciprofloxacin in the 
treatment of otitis externa, in terms of the cure rate and 
microbial eradication.13 
In a comprehensive systematic review of literature, 
Rosenfeld et al compared antimicrobial versus placebo; 
antiseptic versus antimicrobial; quinolone antibiotic versus 
nonquinolone antibiotic; steroid-antimicrobial combination 
versus antimicrobial alone and antimicrobial-steroid 
combination versus steroid alone for controlling pain due 
to acute ottitis externa. They found that compared with 
placebo, antimicrobials (neomycin/methylprednisolone 
and acetic acid/glyceryl triacetate) were associated with a 
significant increase in clinical cure rate at 3 to 10 days 
(RD 0.46, 95% CI: 0.29, 0.63, p<0.001; 2 RCTs, n=89) 
and bacteriological cure rate (RD 0.61, 95% CI: 0.46, 
0.76, p<0.001; 2 RCTs, n=112). They also highlighted 
that quinolone antibiotics (ofloxacin, ciprofloxacin with and 
without dexamethasone or hydrocortisone) were 
associated with a significant increase in bacteriological 
cure rate compared with nonquinolone antibiotics 
(gentamicin, tobramycin, polymyxin/hydrocortisone plus 
neomycin and oxytetracycline), (RD 0.08, 95% CI: 0.006, 
0.16, p=0.035; 6 RCTs, n=980).14 In our study we did not 
evaluate bacteriological cure rate yet clinical cure rate 
was significantly better with3% ciprofloxacin-1% 
Dexamethasone. 
Kaushik V, et al in another systematic review assessed 
the effectiveness of different interventions for acute otitis 
externa. Nineteen randomized controlled trials with a total 
of 3382 participants were included.  Authors summarized 
that topical treatments alone, as distinct from systemic 
ones, are effective for uncomplicated acute otitis externa. 
In most cases the choice of topical intervention does not 
appear to influence the therapeutic outcome significantly. 
Given that most topical treatments are equally effective, it 
would appear that in most cases the preferred choice of 
topical treatment may be determined by other factors, 
such as risk of ototoxicity, risk of contact sensitivity, risk of 
developing resistance, availability, cost and dosing 
schedule. Patients who are prescribed with antibiotic/ 
steroid drops can expect their symptoms to last for 
approximately six days after treatment has begun. 
Patients with persisting symptoms beyond two weeks 
should be considered treatment failures and alternative 
management should be initiated.15 
In summary, based on present study results and on the 
relevant literature review the evidence is convincing that 
steroid-antibiotic wick is better in pain control associated 
with acute ottitis externa when compared to antiseptic 
wick alone. Outcomes of the study serve as an 
understanding of two different treatment options for the 
management of pain associated with acute otitis externa 
in our population. We recommend further randomized 
controlled trials with larger sample size to extend the 
validity of results to the general population. 
C o n c l u s i o n  
Treatment with 3% ciprofloxacin-1% Dexamethasone was 
found to be significantly better than 10% Icthammol 
glycerin in patients with acute otitis externa in terms of 
associated pain control. Outcomes of the study do serve 
as an understanding of two different treatment options for 
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the management of pain associated with acute otitis 
externa. We recommend further randomized controlled 
trials with larger sample size to extend the validity of 
results to general population. 
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